Details of issuance or disposal
Report on the exercise status of Series 2 Stock Acquisition Rights
Shares delivered during the period: 0 shares (new shares: 0 shares; transferred treasury shares: 0 shares)
Total nominal exercise amount during the period: ¥0; estimated net proceeds: Not disclosed
As 0 shares were delivered during the period, dilution during the period was equivalent to 0% (the document does not specify a dilution rate)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Report on the exercise status of Series 2 Stock Acquisition Rights |
| Number of shares to be issued or disposed of | Shares delivered during the period: 0 shares (new shares: 0 shares; transferred treasury shares: 0 shares) |
| Amount of funds to be raised | Total nominal exercise amount during the period: ¥0; estimated net proceeds: Not disclosed |
| Dilution Rate | As 0 shares were delivered during the period, dilution during the period was equivalent to 0% (the document does not specify a dilution rate) |
| Total number of issued shares | As of 28 February 2026: 7,106,900 shares → Not disclosed |
| Exercise price | ¥579; fixed exercise price, not subject to adjustment |
| Number of Stock Acquisition Rights | Total number issued: Not disclosed; unexercised balance as of 28 February 2026: ¥2,295.503 million; unexercised balance as of 31 March 2026: ¥2,295.503 million |
| Most recent equity financing | Timing 24 July 2025 / Type Issuance of Series 2 Stock Acquisition Rights / Amount Total nominal issuance amount: Not disclosed |
Items this document does not state (20)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.These are stock acquisition rights with a fixed exercise price, and the exercise price is not subject to adjustment. However, the company disclosed the exercise status from the perspective of providing information to shareholders and investors.